These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Malaria therapy in HIV: drug interactions between nevirapine and quinine. Uriel A; Lewthwaite P Int J STD AIDS; 2011 Dec; 22(12):768. PubMed ID: 22174067 [TBL] [Abstract][Full Text] [Related]
43. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America. Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062 [No Abstract] [Full Text] [Related]
44. Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children. Anabwani G; Canfield CJ; Hutchinson DB Pediatr Infect Dis J; 1999 May; 18(5):456-61. PubMed ID: 10353520 [TBL] [Abstract][Full Text] [Related]
45. An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia. Dell'Acqua R; Fabrizio C; Di Gennaro F; Lo Caputo S; Saracino A; Menegon M; L'Episcopia M; Severini C; Monno L; Castelli F; Angarano G Malar J; 2017 Apr; 16(1):149. PubMed ID: 28410610 [TBL] [Abstract][Full Text] [Related]
46. [A Splenic Infarct Developing After Plasmodium falciparum Infection]. Turan H; Togan T; Oğuz H; Arslan H Turkiye Parazitol Derg; 2015 Mar; 39(1):60-2. PubMed ID: 25917586 [TBL] [Abstract][Full Text] [Related]
47. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa. Lachish T; Bar-Meir M; Eisenberg N; Schwartz E J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401 [TBL] [Abstract][Full Text] [Related]
48. Prevention and treatment of malaria in UK travellers. Evans MR; Day JH; Behrens RH Hosp Med; 2000 Mar; 61(3):162-6. PubMed ID: 10789384 [TBL] [Abstract][Full Text] [Related]
49. Malaria chemoprophylaxis regimens: a descriptive drug utilization study. Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849 [TBL] [Abstract][Full Text] [Related]
50. Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study. Bruneel F; Tubach F; Mira JP; Houze S; Gibot S; Huisse MG; Megarbane B; Choquet C; Corne P; Peytel E; Villers D; Camus C; Bouchaud O; Caumes E; Girard PM; Simon F; Kalloumeh A; Roy C; Durand R; Le Bras J; Matheron S; Wolff M; Intensive Care Med; 2016 Oct; 42(10):1588-1596. PubMed ID: 27169586 [TBL] [Abstract][Full Text] [Related]
51. [The proper use of antimalarial drugs currently available]. Bourgeade A; Delmont J Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393 [TBL] [Abstract][Full Text] [Related]
52. Recrudescence of Plasmodium falciparum malaria contracted in Lombok, Indonesia after quinine/doxycycline and mefloquine: case report. Tish KN; Pillans PI N Z Med J; 1997 Jul; 110(1047):255-6. PubMed ID: 9251712 [TBL] [Abstract][Full Text] [Related]
54. Trouble from the tropics: challenges in managing malaria in Rhode Island. Dworkin J; Janvier M; Treaba D; Gardner A R I Med J (2013); 2013 May; 96(5):40-2. PubMed ID: 23641463 [TBL] [Abstract][Full Text] [Related]
55. [Gastrointestinal symptoms may reflect complicated falciparum malaria]. Kästner M; Hemmer CJ; Reisinger EC Dtsch Med Wochenschr; 2024 Apr; 149(8):454-457. PubMed ID: 38565119 [TBL] [Abstract][Full Text] [Related]